Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 195-200 , August 2004

The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis

  • Anja Wittkowski

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-161-291-5881; fax: +44-161-291-5882
    • Academic Division of Clinical Psychology, School of Psychiatry and Behavioural Sciences, University of Manchester, 2nd Floor Education and Research Centre, Wythenshawe Hospital, Manchester M23 9LT, UK
    • ,
  • Helen L. Richards

      Affiliations

    • Department of Behavioural Medicine, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK
    • Dermatology Centre, School of Medicine, University of Manchester, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK
    • ,
  • Christopher E.M. Griffiths

      Affiliations

    • Dermatology Centre, School of Medicine, University of Manchester, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK
    • ,
  • Chris J. Main

      Affiliations

    • Department of Behavioural Medicine, Hope Hospital, Salford Royal Hospitals NHS Trust, Manchester, UK

Received 16 July 2002 ,Accepted 12 August 2003.

References 

  1. Holden CA, Parish WE. Atopic dermatitis. In:  Champion RH,  Burton JL,  Burns DA,  Breathnach SM editor. Textbook of dermatology. Vol 1. 6th ed. Oxford: Blackwell Science; 1998;
  2. Merk H. Clinical symptoms of atopic eczema. In:  Ruzicka T,  Ring J,  Przybilla B editor. Handbook of atopic eczema. Berlin: Springer Verlag; 1991;
  3. Schmied C, Saurat J-H. Epidemiology of atopic eczema. In:  Ruzicka T,  Ring J,  Przybilla B editor. Handbook of atopic eczema. Berlin: Springer Verlag; 1991;
  4. Schulz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in North Europe: an international questionnaire study. J Am Acad Dermatol. 1996;34:760–764
  5. Woodruff PWR, Higgins EM, du Vivier AWP, Wessely S. Psychiatric illness in patients referred to a dermatology–psychiatry clinic. Gen Hosp Psychiatry. 1997;19:29–35
  6. Ginsburg IH. The psychosocial impact of skin disease. Dermatol Clin. 1996;14:473–484
  7. Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50:11–15
  8. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000;143:979–982
  9. Jordan JM, Whitlock FA. Emotions and the skin: the conditioning of scratch responses in cases of atopic dermatitis. Br J Dermatol. 1972;86:574–585
  10. Ginsburg IH, Prystowsky JH, Kornfeld DS, Wolland H. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol. 1993;32:656–660
  11. Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci. 1997;14:63–67
  12. King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res. 1991;35:697–706
  13. Garrie EV, Garrie SA, Mote T. Anxiety and atopic dermatitis. J Consul Clin Psychology. 1974;42:742
  14. Linnet J, Jemec GBE. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol. 1999;140:268–272
  15. Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med. 1985;20:425–429
  16. Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want?. Clin Exp Dermatol. 1993;18:516–522
  17. Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol. 1995;133:575–578
  18. Eun HC, Finlay AY. Measurement of Atopic Dermatology Disability. Ann Dermatol. 1990;2:9–12
  19. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RDR, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol. 1993;129:422–430
  20. Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. Br J Dermatol. 1999;141:698–702
  21. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37:41–49
  22. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216
  23. European Task Force on Atopic Dermatitis . Severity scoring of atopic dermatitis: the SCORAD index. Dermatology. 1993;186:23–31
  24. Ginsburg IH, Link BG. Feelings of stigmatisation in patients with psoriasis. J Am Acad Dermatol. 1989;20:53–63
  25. Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32:587–591
  26. Schmid-Ott G, Jaeger B, Kuensebeck H-W, Ott R, Lamprecht F. Dimensions of stigmatization in patients with psoriasis in a “questionnaire on experience with skin complaints”. Dermatology. 1996;193:304–310
  27. Kent G. Correlates of perceived stigma in vitiligo. Psychol Health. 1999;14:241–251
  28. Kent G, Al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–333
  29. Schmid-Ott G, Kuensebeck H-W, Jaeger B, Werfel T, Frahm K, Ruitman J, et al. Validity study of the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol. 1999;79:443–447
  30. Ginsburg IH, Link BG. Feelings of stigmatisation in patients with psoriasis. J Am Acad Dermatol. 1989;20:53–63
  31. Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50:11–15
  32. Wittkowski A. Research into the impact of eczema on the quality of life. Exchange. 2000;98:22–23
  33. Herd RM, Tidman MJ, Ruta DA, Hunter JAA. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol. 1997;136:502–507
  34. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  35. Lewis G, Wessely S. Comparison of the General Health Questionnaire with the Hospital Anxiety and Depression Scale. Br J Psychiatry. 1990;157:860–864
  36. Johnston M, Pollard B, Hennessey P. Construct validation of the Hospital Anxiety and Depression Scale with clinical populations. J Psychosom Res. 2000;48:579–584
  37. Rosenberg M. Society and the adolescent self-image. Middletown (CT): Wesleyan Univ. Press; 1989; reprint edition
  38. Gray-Little B, Williams VSL, Hancock TD. An item response theory analysis of the Rosenberg Self-Esteem Scale. Pers Soc Psychol Bull. 1997;23:443–451
  39. Watson D, Fiend R. Measurement of social–evaluative anxiety. J Consult Clin Psychol. 1969;33:448–457
  40. Turner SM, McCanna M, Beidel CD. Validity of the social avoidance and distress and fear of negative evaluation scales. Behav Res Ther. 1987;25:113–135
  41. Leary MR, Rapp SR, Herbst KC, Exum ML, Feldman SR. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol. 1998;17:530–536
  42. Fleischer AB, Rapp SR, Reboussin D, Vanarthos JC, Feldman SR. Patient measure of psoriasis severity with a structured assessment. J Invest Dermatol. 1994;102:967–969
  43. Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996;106:183–186
  44. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44–47 supplement
  45. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol. 1996;135:509–515
  46. Silverstone PH. Poor efficacy of the Hospital Anxiety and Depression Scale in the diagnosis of major depressive disorder in both medical and psychiatric patients. J Psychosom Res. 1994;38:441–450
  47. Rosenthal R, Rosnow RL. Essentials of behavioral research: methods and data analysis. 2nd ed. New York: McGraw-Hill, Inc; 1991;
  48. Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995;63:624–635
  49. Jaspers JPC, Span L, Molier L, Coenraads PJ. A multimodal education and treatment program for young adults with atopic dermatitis: a randomized controlled trial. Dermatol Psychosom. 2000;1:148–153

PII: S0022-3999(03)00572-5

doi: 10.1016/S0022-3999(03)00572-5

Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 195-200 , August 2004

Article Tools